Leveraging allogeneic dendritic cells for neoantigen cancer vaccines

by Impact Journals LLCThe use of PDC*vac platform to develop NeoAg-based cancer vaccines. Credit: 2023 Hannani et al.A new research perspective was published inGenes & Canceron January

Updated on: December 28,2023 10

Leveraging allogeneic dendritic cells for neoantigen cancer vaccines

by Impact Journals LLCThe use of PDC*vac platform to develop NeoAg-based cancer vaccines. Credit: 2023 Hannani et al.A new research perspective was published inGenes & Canceron January

Updated on:December 28,2023 10

Experts reach consensus on gene therapy carcinogenicity risks

byMary Ann Liebert, IncCredit: CC0 Public DomainAnarticlein the journalHuman Gene Therapydescribes the consensus reached by invited experts who participated in a meeting

Updated on: September 03,2024 0

Experts reach consensus on gene therapy carcinogenicity risks

byMary Ann Liebert, IncCredit: CC0 Public DomainAnarticlein the journalHuman Gene Therapydescribes the consensus reached by invited experts who participated in a meeting

Updated on:September 03,2024 0

A non-coding RNA lasso catches proteins in breast cancer cells

by Lisbeth Heilesen,Aarhus UniversityThe authors show that the long non-coding RNA called A-ROD (Activating Regulator Of DKK1 expression) is only functional the moment it is released from chroma

Updated on: May 20,2024 5

A non-coding RNA lasso catches proteins in breast cancer cells

by Lisbeth Heilesen,Aarhus UniversityThe authors show that the long non-coding RNA called A-ROD (Activating Regulator Of DKK1 expression) is only functional the moment it is released from chroma

Updated on:May 20,2024 5

New discoveries in circadian rhythms provide insight into cancer treatment

by Tiffany Trent,Virginia TechCarla Finkielstein shares notes with visiting student Xianlin Zou. Credit: Virginia TechIn a recent paper inScience Signaling, associate professor of cell and

Updated on: April 07,2024 13

New discoveries in circadian rhythms provide insight into cancer treatment

by Tiffany Trent,Virginia TechCarla Finkielstein shares notes with visiting student Xianlin Zou. Credit: Virginia TechIn a recent paper inScience Signaling, associate professor of cell and

Updated on:April 07,2024 13

Targeted hope for metastatic cancer

by Paul Mayne,University of Western OntarioCancer cell during cell division. Credit: National Institutes of HealthA cancer diagnosis is tough enough to hear, but a diagnosis that cancer has spre

Updated on: April 01,2024 10

Targeted hope for metastatic cancer

by Paul Mayne,University of Western OntarioCancer cell during cell division. Credit: National Institutes of HealthA cancer diagnosis is tough enough to hear, but a diagnosis that cancer has spre

Updated on:April 01,2024 10

The new prostate cancer blood test with 94 per cent accuracy

byUniversity of East AngliaProstate cancer cells. Credit: NIH Image GalleryResearchers at the University of East Anglia have helped develop a new blood test to detect prostate cancer with greate

Updated on: January 12,2024 10

The new prostate cancer blood test with 94 per cent accuracy

byUniversity of East AngliaProstate cancer cells. Credit: NIH Image GalleryResearchers at the University of East Anglia have helped develop a new blood test to detect prostate cancer with greate

Updated on:January 12,2024 10

Cesarean section tied to higher risk for later leukemia in offspring

Elective cesarean section (CS) is associated with an increased risk for leukemia in offspring, according to a systematic review and meta-analysis published online Aug. 24 inHematological Oncolog

Updated on: January 02,2024 9

Cesarean section tied to higher risk for later leukemia in offspring

Elective cesarean section (CS) is associated with an increased risk for leukemia in offspring, according to a systematic review and meta-analysis published online Aug. 24 inHematological Oncolog

Updated on:January 02,2024 9

The origin-of-life molecule, a key to cancer research

byUniversity of SevilleSchematic model of the regulation and role of RNAPII-generated nascent RNA to guide DNA end resection and DSB repair by HR. Credit:Nature Communications(2022).

Updated on: January 04,2024 10

The origin-of-life molecule, a key to cancer research

byUniversity of SevilleSchematic model of the regulation and role of RNAPII-generated nascent RNA to guide DNA end resection and DSB repair by HR. Credit:Nature Communications(2022).

Updated on:January 04,2024 10

New study highlights rapid adoption of clinical research results into chemotherapy prescribing patterns

by National Comprehensive Cancer NetworkCredit: Pixabay/CC0 Public DomainNew research inJNCCN—Journal of the National Comprehensive Cancer Networkevaluates how an important analysis on loc

Updated on: February 01,2024 10

New study highlights rapid adoption of clinical research results into chemotherapy prescribing patterns

by National Comprehensive Cancer NetworkCredit: Pixabay/CC0 Public DomainNew research inJNCCN—Journal of the National Comprehensive Cancer Networkevaluates how an important analysis on loc

Updated on:February 01,2024 10

Head and neck cancer organoids as a step towards personalized treatments

byHubrecht InstituteHNC organoids from the biobank. Credit: Organoid group, copyright Hubrecht Institute.Head and neck cancer (HNC) is an overarching term used for several types of cancer, inclu

Updated on: January 07,2024 9

Head and neck cancer organoids as a step towards personalized treatments

byHubrecht InstituteHNC organoids from the biobank. Credit: Organoid group, copyright Hubrecht Institute.Head and neck cancer (HNC) is an overarching term used for several types of cancer, inclu

Updated on:January 07,2024 9

Head and neck cancer: Identifying markers to facilitate better treatment in the future

byMedical University of ViennaCredit: AI-generated imageMalignant tumors in the head and neck region are very heterogeneous and therefore difficult to treat. In addition, the lack of prognostic

Updated on: January 07,2024 10

Head and neck cancer: Identifying markers to facilitate better treatment in the future

byMedical University of ViennaCredit: AI-generated imageMalignant tumors in the head and neck region are very heterogeneous and therefore difficult to treat. In addition, the lack of prognostic

Updated on:January 07,2024 10

Neoantigen DNA Vaccines: A Promising Approach for Triple Negative Breast Cancer

Among innovative strategies, neoantigen DNA vaccines have emerged as a particularly promising approach, offering hope for improved patient outcomes.

Updated on: November 15,2024 0

Neoantigen DNA Vaccines: A Promising Approach for Triple Negative Breast Cancer

Among innovative strategies, neoantigen DNA vaccines have emerged as a particularly promising approach, offering hope for improved patient outcomes.

Updated on:November 15,2024 0